Full Transcript Introduction and Professor Laucu2019s Background 0:08 - Well, Professor Gordan Lauc, it's such an honor to have you on the segment of 0:12 Regenerative Medicine Summit. Thank you so much for joining me. 0:16 - Thank you for the invitation. It's a pleasure to be here 0:20 - And I'm really excited about this, the subject because I get into glycoprotein is quite a 0:27 bit back in the, in the 90s actually and I know there's tremendous amount of research 0:34 since then. I know there's a at that time like a segment 0:37 and harpers biochemistry about lichens and glycoprotein and they're signaling 0:44 and all that. So I'm excited but let's first tell the 0:47 audience a little bit about who you are and and and the amount of research that you've done in 0:53 this field. Professor Gordan Lauc is a professor of by 0:57 chemistry and molecular biology at the University of Zagreb, 1:02 director of the National Center of Scientific Excellence in Personalized healthcare. 1:08 Honorary professor at the University of Edinburgh and the King's College London and 1:14 member of the john Hopkins Society of Scholars in 2017 he initiated the launch of 1:21 human glycoprotein decked and is one of its two co directors. 1:26 His research team is pioneering, high throughout high through high throughput google 1:32 iconic analysis and the application of blackened by markers in the field of precision 1:38 medicine by combining google iconic data with extensive genetic epigenetic biochemical 1:45 and physiological data and systems biology approach. 1:49 They're trying to understand the role of lichens and normal physiology and disease and 1:54 professor Lauc co authored over 200 research articles that are cited over 10,000 2:01 times in 27. He founded genomes, a biotech company that is 2:07 currently the global leader and high throughput glycol mix research in Gino's led to the 2:13 development of the Glicken Age test of biological age. 2:18 Well this is going to be exciting. I'm really because this, 2:21 this is a field that a lot of, I mean people mostly don't know about this. 2:27 I mean this is so kind of out there and and it's it's just gaining momentum and it 2:32 sounds like you are really driving that momentum. 2:37 - Yes. Unfortunately, many scientists still ignore 2:41 black simply because they're very difficult to study. 2:46 So for example, if we think about the protein, a single protein is 2:53 a they created with black icons to make hundreds or even thousands of glycoprotein. 2:59 So instead of looking at single molecules, scientists would have to look at the hundreds 3:03 or thousands of molecules and many of them still avoided that trouble and simply ignore 3:09 likens. But the field is definitely gaining momentum 3:13 actually a couple of weeks ago on overpriced and chemistry was the word in the field. 3:17 The first one to Caroline virtually for developing some of the tools to study girl 3:22 icons. And I think the majority of people now 3:26 understand the lycans are important but still stay away from them because it's difficult
Why Glycans Matter in Biology 3:33 to study them. The way I usually try to explain the importance 3:39 of guidance is by using an example of a bird without a single feather. 3:46 So it is still a bird and you could do a lot of good research on that bird. 3:51 Study physiology of the bird eyesight, eyesight of the bird walk of the bird. 3:56 But if you are studying the bird without the feather, you cannot even imagine flying because 4:03 bird without its feathers cannot fly. And the same goes for proteins. 4:06 So if we look at proteins only at the level we are missing a huge element 4:13 of complexity which actually enabled the life in the way we know it today. 4:20 - So glad icons in itself is I mean from my understanding in the past was that it's kind of 4:26 like a signaling molecule in a way. So it's kind of like antenna at the outside of 4:32 cellular membrane and there's a lot of communication that takes place in regards to 4:37 the lycans. - So it is a part of a protein molecule. 4:42 So the majority of proteins will have this glass icons attached, 4:45 you can think about the recent antennas and occasionally indeed they serve as a receptor 4:51 for something to attach to that antenna. But they're also part of the molecular 4:56 structure and alternative regulation, meaning adding different likens to the 5:03 same protein. It's functionally very similar to coding 5:06 mutation. So the coding mutation is a change in the gene 5:09 sequence which is changing them in acid sequence, which is changing the structure of a 5:13 protein and we know that some mutations can be little. 5:16 So you have a mutation which can kill you or make you sick. 5:20 The same goes for alternative like insulation So if we are putting the wrong, 5:25 like on at the given regulation site, the function of protein is altered and the protein 5:31 cannot function normally. And actually there is a series of diseases 5:35 called the congenital disorders of accumulation which are very rare but kids with this type of 5:41 disease are dying at very engaged because we cannot in majority of cases and we 5:48 cannot live with our glider. So without argh likens we are not functional, 5:52 not only us, any organism on the planet cannot live without. 5:57 - So help me understand a little bit more in regard to click in. 6:02 So you're telling me that. So we're looking at the bird, 6:06 you know, which is without the feathers, that is kind of like just the protein. 6:10 So it's like a, the physiology, it's like the, it's almost like dumbing the bird down in a way 6:17 and then we add the feathers which is an additional complexity and all of a sudden then 6:23 now we can study how the bird is flying and the patterns is flying. 6:26 So how, what functionalities are added then with the Glickman's you know that 6:33 we are studying that's let's say for instance, I mean what are some normal functions in the 6:39 body that would not take, I mean like you said every function but yeah, 6:44 help me understand a little bit more kind of in layman's terms, 6:47 - We can make one very simple example And these are antibodies. 6:53 So antibodies are the main weapon of our immune system but the protein 6:59 part of an antibody it's actually defining which antigens that bind. 7:05 But the moment when this protein part is defined we still do not know what type of anti 7:12 genitals. It could be a virus, it could be a bacteria, 7:15 it could be food, it could be something we inhale and the response of our immune system 7:22 has to be very different because we activate different branches of the immune system to kill 7:27 viruses to kill bacteria. Or even we have to dampen our immune system to 7:32 tolerate things we eat or things we inhale. And this is being done by likens. 7:37 So by putting different likens to the globalists we decide to which 7:44 receptors will these so called FC or concept crystallize, herbal or constant region of the 7:51 antiballistic will bind and then activate the effect of functions. 7:56 For example we did some studies in people having pneumonia and 8:02 pneumonia which is not for viral log origin and pneumonia of bacterial origin 8:09 will cause completely different accumulation of antibodies because our immune system has to use 8:15 different weapons. Different effective functions to kill viruses 8:20 and to kill bacteria. So immune system and inflammation are important 8:26 aspects which are being regulated by Greitens but this is just one of the examples for 8:31 example all the main brain receptors that causality there half life is determined by like 8:36 isolation and also it is known for example that one specific type of insulation is 8:43 linked with a very high risk of diabetes because our glucose sensing and glucose and 8:50 insulin release mechanisms are regulated by a cancelation. 8:52 So really all aspects of biology have likens involved but in 8:59 most of them we didn't study likens sufficiently to understand it
How Glycans Regulate Immune Function 9:05 - And it is mostly because it is such a complex science. I mean like like you're saying we have we have 9:11 a limited amount of proteins, you know. And so those are fairly easy to to study and 9:17 then we add then the combination of the numbers of different Billikens. 9:22 I mean are there like in proteins we have touring we have tire scene. 9:29 We have all these different amino acids and a combination of these and creates a peptide 9:36 if it's a smaller that has a very specific singling, you know. 9:40 And you know, peptide science is really kind of moving forward and then in Glickman's, 9:46 is it the same thing that you have? Certain like manos and and you know, 9:52 different kind of sugar molecules that become that's a limited amount of them? 9:58 Or is it just a huge amount of different, you know, look likens 10:01 - It's a huge amount of different structures actually. 10:05 It's an entire new complexity level because both D. 10:10 N. A. And RNA and proteins are linear molecules. 10:14 If you write down the sequence of nucleotides in the D. 10:18 N. A. You know the sequence of R. N. A. 10:20 And you know the sequence of a protein glycogen. Zar branched nonlinear structures and 10:27 their structure is not encoded directly in the D. N. 10:30 A. It's encoded in a network of genes. 10:34 So for example, for immunoglobulin gene where we did a series of large studies, 10:39 we know it's over 40 genes which have to work together in the network to decide which kind 10:46 of gliding structure to put on I. G. So on the majority of proteins, 10:51 the number of gliders which are being attached is not huge. 10:55 It can be from a few dozen to maybe a few 100 but they can be put on a 11:01 different locations and a protein so different like insulation sites. 11:06 Each protein have a multiple mutilation sites. So the entire complexity is enormous 11:13 and we still don't fully understand it. And until recently it was really difficult to 11:18 study because there were no reliable high throughput quantitative methods to even 11:24 see how the insulation looks like. So if we think about genetics, 11:29 this would be like in the eighties or early nineties. 11:32 But when it was really difficult to read the sequence of A D. 11:36 N. A. That was a challenge. 11:38 But with the development of tools which happened in the nineties for molecular biology, 11:42 we were able to start to sequence D. N. A. And now for maybe a decade we really have tools 11:48 which enable us to reliably address voting like insulation. 11:54 and this is why the field is blooming because we are doing large studies studying thousands 11:59 of people to the humanlike on project. We already studied over 200,000 people and 12:05 generated like and data which showed that people are different, 12:09 that glass icons are predicting position to different diseases to respond to some 12:15 therapists and so on because you know, everything is correlated just, 12:19 we don't think it that way. For example, blood groups are lichens, 12:22 chemical, E, A B and O blood groups, Argh likens majority of um cancer 12:29 markers, argh likens so we know about them but people don't think about them as likens, 12:35 they just think them as a blood groups or cancer antigens but they're there. 12:40 Most of them are actually likens. 12:43 - So what do you see lycans, I mean what impact do you see this 12:49 research having in and in people's lives, you know, directly in and battling 12:56 disease and anti aging and you know, what impact do you see in people's lives? 13:02 - So unfortunately like comics is only slowly entering the diagnostics arena, 13:08 so because formal diagnostics is extremely conservative, you know, 13:12 at the global level, we introduced one or two biomarkers per year, 13:17 but first black and biomarkers have already approved for clinical use. 13:22 So in a maybe a decade there will be a lot of black and biomarkers in diagnostics. 13:29 What is happening on the side of diagnostics is that there are some tests which are being 13:35 marketed as a lifestyle markers like the glycol test of biological age where of course I'm 13:42 heavily conflicted because I am the inventor of that test. 13:45 And So this test is used currently by I think over 500 13:51 different clinics all around the world where people are using it to 13:57 navigate personalized healthy aging. Because one of the key problems we have in 14:04 medicine in general is that all both pharmacological and lifestyle um 14:10 therapist or approaches are developed on the basis of a standard human But there is no 14:17 standard human, none of us is a standard human. Each of us is a little bit different. 14:22 And this is why we know that today 80% of the smart drugs, 14:26 all those expensive sciences, smart drugs are being wasted because we give them to people who 14:32 do not respond the same goes for lifestyle interventions. 14:36 So different diets, different exercise regimes, different supplements are given to people who 14:42 do not benefit from them. Because we do not have tools to say whether it 14:48 actually works or not because there is a rich perch saying, 14:51 you know that the compound X. Is helping in a condition B but it might not be 14:57 working for me. It might maybe working for you.
Glycan Complexity and Human Glycome Research 15:00 So what what the glycogen age test is doing is actually showing whether specific intervention 15:06 works for me and it can give a result in a reasonable time frame of a couple of months. 15:13 So as a lycan age is a company which is on the market for, 15:17 I believe slightly over two years already have I think over 15,000 15:24 customers which are using this test to see whether some lifestyle 15:30 interventions they do actually benefit them or not. 15:35 And for example, one of the first things we learned where we're actually shocked is to see 15:40 that the majority of people, especially the middle aged people when they start training, 15:46 they actually over exercise their overtrained and we see actually damage and not to benefit 15:52 from physical activity because um it was actually the food industry which created 15:59 dogma that you can sweat out the bad guy, which is false. 16:04 You cannot sweat out the bad diet if your diet is bad, 16:07 you cannot access that enough to fix the diet. 16:12 The other thing which is wasteful, largely overlooked is the microbiome, 16:18 especially in the US with so much ultra processed food with food, 16:23 which has a shelf life of of a half a year or year, you know that there are chemicals there 16:29 which kills microbes and if you eat that food, it is killing your own microbes. 16:35 And if you kill your own microbes, then you cannot function normally. 16:39 So people do things then try to change everything. 16:45 And so many people overdo it, they combine different interventions, 16:51 different dietary regimes and actually do them self damage. 16:55 And we have seen it so many times that you test somebody who thinks I'm doing everything 17:01 perfectly and then it turns out it's not that perfect and then you just have 17:08 to kind of calm down a bit. You know don't don't do everything at the same 17:12 time or the classical thing is you know somebody is not doing anything and then tries 17:19 just going to the gym every day and takes a personal trainer and you know just press it out 17:25 and then you say look at your you're getting too much pro inflammatory, 17:30 you know all these exercises pro inflammatory, you have to relax more and then just by 17:35 exercising a little bit less things get better. 17:39 So this is something where people are already benefiting from the glycol science 17:45 because you can actually see that what you do either works 17:52 or do not work. 17:55 - So I'm curious to see because you have these genetic tests, 18:00 you know testing genetic snips and and then you get personalized medicine based upon that you 18:06 have this snip so you can take this herb of these nutrients you take you take. 18:11 You know obviously the popularized one is like Mthfr and then you need you know methylated 18:18 folic acid and so forth. So how how does this differ? 18:23 You know learning about the Glickman's than the genetic snips in regards to how to 18:29 personalize what you're eating supplement lifestyle etcetera. 18:35 - So these are two very complementary approaches because what we know today we are what we know 18:40 today is that only approximately 20-30% of diseases and the longevity is actually 18:47 genetic majorities of our lifestyle. And these snips which we read in the genetic 18:53 testing are exactly the same since we were born until we die. 18:59 So our genes do not change. And all the genetic risk factors are predefined. 19:05 So if you have a higher risk for heart attack, genetic risk, 19:10 anything you do will not change that genetic risk, it will change the lifestyle and the 19:17 genetic component. And this is what is being measured by likens. 19:21 So glad icons and genetics are complementary aspects. 19:27 Also one part of Lycans in genetics. So approximately between 30 and 50% of the 19:33 glycol composition is predefined. This is written in our genes. 19:36 There's nothing we can do about it. But the other 50, 19:42 we can change by making a decision to have a different lifestyle. 19:47 So the key difference between icons and genetic testing is that you cannot see an effect of 19:54 fear intervention on the genetic risk. 19:58 But you can see it on like this. On the other hand, 20:00 when we see that the glide cancer not ideal, we usually do not know why. 20:07 But then we can use genetics to give us part of the guidance and and interviews to see what 20:14 people are doing. And the research then can tell us, 20:16 you know, obesity is driving the pro inflammatory aspect. 20:20 It could be sex hormones to be other things which drive the glycol to become more pro 20:25 inflammatory - And so when people do this test then, you know, 20:30 what are they, what are we measuring? And how, 20:35 what do we learn from it that will then give us a a reason to change our 20:41 lifestyle. I mean you're told you know that you know, 20:45 this individual, they may learn that they're exercising too much, 20:49 but how do we, and then he turns that down and then, 20:53 you know, how do we measure differences and what are we looking at? 20:57 - So this guy can age test, which we were talking about. 21:01 This commercial test which is available is measuring glide cons attached to global energy. 21:08 And we know which glide constructors are associated with old age 21:15 with inflammatory diseases, with the risk for cardiovascular events and such things and which 21:21 glass icons are actually suppressing inflammation and we all know that we are young. 21:27 Argh, like is composed in a way that it's actually suppressing inflammation. 21:32 And as we're getting older and as we accumulate low grade chronic inflammation. 21:37 Our guide cons are actually driving this chronic inflammation is the kind of a vicious 21:42 circle where inflammation is driving pro inflammatory glide guns, 21:46 which then drive inflammation. And this is the process which is often referred 21:51 as inflammation inflammation, driving aging And what can be 21:57 seen from measuring likens is how far on that scale of promoting inflammation.
Clinical Uses: Aging, Lifestyle, and Personalized Health 22:04 We already went. So somebody can be chronologically 50 and 22:09 they're like could be like an 80 year old person, 80 year old person or a 20 year old 22:14 person. And of course we don't like to have glass icons 22:17 which are suppressing inflammation because we know that the low grade chronic inflammation is 22:22 one of the key drivers of disease. 22:25 The problem is that we don't know how to do it. 22:28 For example, one of the typical errors people make is there are 22:35 some people who are really trying to optimize hormone levels and in men of course they give 22:41 them testosterone. 22:43 And if the testosterone is not rising enough then they also gave aromatase inhibitors which 22:49 is blocking the conversion of testosterone to estrogen. 22:53 Well actually in both women and men it is estrogen which is promoting this anti 23:00 inflammatory effects of lycans. So instead of trying to to raise the 23:06 testosterone level and stopping the conversion to estrogen, 23:10 we should measure what is the level of this pro inflammatory lichens which are controlled by 23:16 the estrogens actually aromatase can do damage. Although the testosterone is great. 23:21 But you are still pro inflammatory. So this is where this field of light and 23:26 science actually can help because contrary to both the D. 23:31 N. A. Testing and epigenetic testing google icons are 23:35 functional defectors. These are molecules which actually do something. 23:39 So when you measure them and you see oh gosh I have a lot of pro inflammatory likens, 23:43 you know this is bad and if you have a lot of anti inflammatories likens, 23:48 you know this is good while in both the snakes and and and the mutilation sites. 23:55 In the majority of cases we don't know all the functional aspects, 23:59 especially for ventilation. 24:02 - So seeing then, you know, talking about the the pro inflammatory, 24:07 so seeing then that you have a lot of pro inflammatory likens, 24:12 you know, then the intervention would be because obviously exercises you trigger 24:18 inflammation in order to be able to build muscles, you know? 24:23 But if you have a lot of pro inflammatory likens then you need to tone it down and then 24:29 also you need to then say support or reduce the breakdown of estrogen. 24:35 You need to allow estrogen to be there a little bit more so are there than interventions and 24:41 that you can do based upon the test in order and then do follow up test to see are my 24:47 interventions, working - For example what we have done in several occasions, 24:52 we would have a person doing a lot of endurance training 24:59 which is highly pro inflammatory and if they switch to high intensity and terrible training 25:05 which has the majority of beneficial effects of also the long term training we could see that 25:11 the guidelines are becoming less pro inflammatory. 25:14 So it's still, you know, again we cannot say that this works in everybody. 25:20 But our researchers have shown that in many people high intensity interval training is more 25:26 beneficial than than the than the long term training simply because it gives time for 25:33 muscles to to restore their normal physiology. Because you know, 25:37 if you keep exercising your lactate keeps building up and this is definitely not not not 25:43 beneficial. So it doesn't have to be exercising glass, 25:47 it could be exercising different. Also for that, 25:51 we have a very interesting study which was published a couple of months ago. 25:56 There was a large study in europe where 1000 people were first put to the very 26:03 low calorie diet. I believe it was around 800 calories for two 26:07 months. So they lost A lot of weight. 26:11 And I think those who were lost more than 10 kg in two months, 26:15 then they were put on a maintenance diet because nobody can maintain 800 calories diet, 26:20 you know, that's a torture. You don't want to do that. 26:22 So they tried five different maintenance diet different combination of proteins, 26:28 carbohydrates and so on. And what we have seen in glass icons is that in 26:33 each of these diets there are some people who were responding well and some people who were 26:39 not responding well because we are different, especially when it comes to carbohydrates 26:45 because you know, the the abundance of carbohydrates is something which is very recent. 26:51 This was revolutionary. Never present. 26:53 It came together with the agricultural revolution and human started 27:00 to domesticate animals far far earlier than growing a lot of carbohydrates and we 27:07 still have many people who are intolerant to lactose. 27:11 the mutations which enabled us to consume milk Created much 27:17 earlier than the mutations which would enable us to consume a large amount of carbohydrates. 27:22 So probably there are some people among us who can cope with a large amount of carbohydrates, 27:27 but there are many people who cannot. And one of the reasons why the dietary 27:33 recommendations are changing so drastically because you know, 27:36 20 years ago we were all saying, you know, it's a lot of carbohydrates don't eat fat today. 27:41 We say, Oh no, no, no, you should eat that, you should eat protein and don't eat carbohydrates. 27:45 Because there are some people who can cope with carbohydrates and some people who cannot cope 27:52 with a high protein diet. So each of the diets which were tested on these 27:56 1000 people, some people benefited. 27:59 Some people did not respond well. 28:02 And you cannot say by the change in B. M. I, you cannot see that with any kind of other 28:08 markets. But gardens were showing, you know, 28:11 these guys are responding well and the other ones are not. 28:15 - And so with that, because we talked about the pro inflammatory glass icons are are those 28:22 the lichens that you would measure if there's more of those than you know that they're not 28:28 responding well. - So now we are talking only about these 28:31 immunoglobulin glass icons which are more pro inflammatory or maybe some other plasma protein 28:37 likens, which we know that our link with inflammation. 28:39 So if we see that specific diet is not reducing this uh pro inflammatory capacity of a 28:46 glass icon, then we could say, you know, maybe some other diet would be better for you. 28:52 And google icons can tell it reasonably well. You know, 28:56 in a couple of months you can see whether something is working or not. 29:00 And you know, one of the key problems we have as as individuals is that the 29:07 lifestyle interventions are difficult. 29:09 It's not easy to do things which you know, exercise controlling your diet. 29:15 It's not easy. And if you don't see a benefit, 29:18 people don't do it. And health benefits Are manifesting only two or 29:24 three decades after we start doing something and nobody is going to change their lifestyle 29:30 or at least very small amount small number of people will change their lifestyle today for 29:35 benefit which will come in 20 or 30 years. But if there is something quantifiable, 29:40 something you can measure and then you can see that in the three months some of your difficult 29:46 decisions are actually paying off, then people get motivated and this is what we see a lot 29:53 with this like an age company is that people try something, 29:59 they see it works or it doesn't work because they're like an agent going up or down and and 30:04 then change and then they find something which works and this feedback gives them 30:11 motivation to go in that direction. So I really think that I hope that, 30:18 you know, in in 5 to 10 years when this test becomes routine test in a clinical 30:24 laboratories, it could be used to motivate people to live healthier 30:30 because, you know, the problem we have in the modern health care is that we are not trying to 30:36 keep people healthy, we are trying to keep people well 30:43 enough to function and then still to stay our customers and buy the drugs and therapies 30:50 and everything else. So I think the majority of the health care 30:54 systems are now realizing that this will just bankrupt Everybody because,
Glycans vs Genetic Testing 31:00 you know, in us, I think now it's around 20% of GDP which goes to the health care. 31:04 So how high can it go? Will it be 60% of the health care that will 60% 31:11 of the money which will go to health care? And I know that in Europe we have a formal 31:16 priority of the European Commission. Is that from so called in terrible health care. 31:21 When you try to fix something which is broken, we have to switch to the continuous health care 31:27 by helping people to stay healthy. 31:31 And it's not easy because, you know, healthy people don't bring money, 31:35 but healthy people actually do bring money because they work and then they create money. 31:41 So it's complicated. - Yeah. And obviously the issue with sick people is 31:47 that it's a huge burden on taxpayers to support them financially 31:53 because they they're not producing work and then they're sick. 31:57 So now they need financial support to be able to be taken care of. 32:02 So obviously better model would be not to have them sick, 32:06 you know and be healthy and thrive. So what more I mean because like 32:12 inflammatory factors, I mean we look in in blood like c reactive protein and we do another 32:17 test called at our clinic where we measured like from boxing A to you know, 32:23 as a inflammatory marker. So what other things are you looking other than 32:29 inflammation in regards to the the glycol age or like an age? 32:34 Are there a lot of other factors that come along with it other than inflammation that 32:40 you determine as well or how does that differ from other inflammatory markers that we are 32:45 used to seeing. - So majority of current clinical inflammatory 32:50 markers are highly acute meaning they can change a lot from day to day. 32:56 They respond to a small infections, you can have a small bacterial infection somewhere and 33:03 your crp could go through the roof. Gland cans are more the chronic measure. 33:09 So in many global and lycans are measuring inflammation at the chronic level. 33:15 So it's not a short term marker. It's a long term marker. 33:18 It doesn't make sense to measure it more than once in a few months while clear p you measure 33:23 daily. But this is just one aspect of black insulation 33:27 which which can be used and this is the only one which is commercial available today. 33:33 We as the largest hydro particular comic laboratory globally do 33:40 a lot of other studies. For example. 33:43 We are now trying to develop a test which would be more predictive of risk 33:49 of um future diabetes development. So it's measuring kind of a balance of 33:55 metabolism Because you know our ourselves are constantly 34:02 adapting to changing environment and as we are progressing from from a healthy state 34:08 to some kind of prediabetes and diabetes which is today a global burden will have over 34:15 10% of a population that have diabetes now in most of the countries. 34:20 This is a process which takes over a decade to develop. 34:24 And glass icons as a regulatory mechanism which is uh controlling for how long 34:31 will receptor B on the cell membrane the insulin receptor, 34:35 the global transporters there also that and change continuously. 34:39 And when we look some other types of black on. So these are now not even a global icons, 34:44 their icons and some other proteins. We see them changing up to a decade 34:51 before people develop insulin resistance. 34:55 So glad cons try to compensate for this problem. And then at the moment there's a break out of 35:00 the system insulin resistance and finally diabetes develops. 35:05 So also we time this test will also be available where people could actually 35:11 see how far on this path of going from healthy to some kind of a diabetes or 35:18 prediabetes state They already traveled and this is all before the HB one C 35:25 gets altered. So HB one C. 35:28 Is a marker which is changing after the glucose regulation has already been at least part 35:35 the loss. So higher glucose levels result in higher HB 35:39 one C guidelines change before that happened. 35:43 Another very important aspect where lycans will prove to be very beneficial is the the 35:50 perimenopause issue because transition from the regular cycle to menopause is 35:57 a period which takes a number of years and it's heavily under research and the majority
Early Disease Detection and New Biomarkers 36:04 of women in that period get misdiagnosed with different problems. 36:09 They get treat with different diagnosis. They got treated for different issues which 36:14 have which are not real problem. The real problem is hormone deficiency. 36:20 And It's very hard to determine it by measuring hormone levels because hormone levels can vary 36:26 within a day from day to day. So one of the tests today would say you have to 36:31 collect 28 samples every day in a month, measure it and then see what is your hormone 36:36 level. This estrogen has a very strong effect on the 36:41 regulation of I. G. Like regulation by measuring a glide and sample 36:45 at the single time point, we see the the average concentration of I. 36:50 G. In the last few weeks. 36:52 So actually, probably within a couple of years or maybe a little bit more. 36:58 I. G. G. Lycan composition will be equivalent for HBO 37:02 one C. So what is HB A one C. 37:04 For glucose will B I. G. Lycan composition for estrogen levels. 37:10 So there are more and more of this type of test being developed also for for different types of 37:16 liver diseases, for different types of cancers, there will be like on biomarkers which will be 37:22 available to predict what is going on or to help diagnose the disease. 37:30 - So it's and this is exactly what we're missing in healthcare is that, 37:35 you know, blood levels, you know, the body tries to compensate for such a long period of 37:40 time before anything starts to show up in the blood. 37:43 So then measuring. So it's a very kind of late stage type of 37:49 diagnostic to see what's going on in the bloodstream. 37:52 So then measuring the Glickman's will give us the opportunity to start to see when the 37:59 process is moving towards a disease state, you know, way earlier so that you can do an 38:05 intervention and recognizing that something is going on, 38:09 you know, before way before it becomes a disease. 38:13 - So I think something which is extremely important for for the entire health care system 38:19 to acknowledges that we still know very little about the biology and immunology 38:26 and all physiological processes. And I think this became so clear in this 38:31 pandemic, you know that we don't understand anything. 38:33 We don't know how things work and we have to learn. 38:37 We have to try and we have to develop better ways how to quantify An 38:44 individual. For example, there is a paper now being under 38:47 review in which we participated which is called the molecular human. 38:52 They measured over 6000 different molecular phenotype, metabolic, 38:57 comic, platonic glide comic to try to understand an individual 39:04 person because we are all different. This is what keeps us a suspicious alive 39:11 because we lived through the ice age. We live through the much warmer climate than 39:15 today. People can survive in in a tropical climate in 39:20 the desert or at uh frozen uh completely frozen land. 39:26 People can survive and this is because we are different and we have to acknowledge that we 39:32 are different and then approach every patient individually. 39:38 We still don't have this knowledge. So if if you are seeing a patient, 39:42 you have no ideas how different he is from a previous or the next patient at molecular 39:49 level gene sequencing of course will give a part of information. 39:54 So finding mutations, pharmacogenomics is now really moral, 39:59 is becoming a standard. So you know that some mutations and some drugs 40:02 should not mix not to genomics is making a progression in the field of 40:08 oncology. Yes, genetic analysis can help a lot. 40:12 But in the majority of chronic diseases it's it's a lifestyle, 40:17 it's not genes which make you obese and it's not genes which make you give you metabolic 40:23 syndrome or insulin resistance. It's your lifestyle and gliding tests can 40:29 really hear be helpful. So they're still not the formal diagnostic test 40:34 because the key problem for gliders to become a diagnostic test is that the methods to analyze 40:41 the glass icons have to be certified. And as a human like on project we talked to the 40:46 all the instrument providers and just a couple of weeks ago we had a meeting of the human 40:50 gliding project. I spoke to one of the big companies and ask 40:54 them, okay so what do you need to make an I. V. D. 40:59 Certification of this specific machine? And they said you know I have to sell at least 41:03 a couple 100 of these machines in Europe and to sell a couple 100 of machines then you have to 41:08 have pests which people will do on these machines. 41:11 So it's a kind of we should circulate cannot get out until there are no tests. 41:17 You cannot certify machines when there are no certified machines, 41:20 you cannot develop tests. So this is what human blackened project is 41:24 trying to to help so have the the instruments and the re agent providers to create tools 41:31 for black and tests to become available - And in the process and you're you're needing to 41:37 have it on the research level to make sure that these tests can be then 41:43 commercially beneficial to the public. And you know obviously that that becomes 41:50 the first step and then you can then roll out the test. Yeah 41:53 - So first step is to have as many healthcare providers as possible. 42:00 Use indeed the research on the test to actually help their patients because the healthcare 42:06 provider the certified decisions or even nutritionists or or whoever is working with the 42:12 people. They can use all the information available even 42:15 if it's not a diagnostic test. So test which can help a physician help their 42:22 patient can be useful even before it becomes diagnostic test. 42:27 Of course it has to be used by people with more experience with more training uh has to be with 42:34 all the all the restrictions there but people can use it. 42:39 So once we have research, once we have positions using this research only test an 42:44 actual majority of genetic tests today for researchers only they're not diagnostic tests 42:50 and then this will create a potential market which then can be converted to a gnostic market 42:57 diagnostic market. So it it takes time.
Research to Clinical Adoption and Future Applications 43:00 But this is for each test, it goes the same way. 43:05 - And one thing because I do a lot of integrative oncology in regards to 43:11 cancer than what what do you how do you see that they liken? 43:16 I mean obviously inflammation drives any kind of cancer process but inflammation drives a lot 43:22 of things. So what are some of the things in regards to 43:26 google icons that can then enable a person to do more preventative medicine and recognize 43:33 that they are moving in the right direction or that they therapy they're using is beneficial 43:39 to them. - So actually there is first approved 43:45 laboratory developed tests from for ovarian cancer is being marketed by the intervention in 43:51 in san Francisco. So it's looking at the black opap ties and 43:55 helping the diagnosis of ovarian cancer. And there's a lot of research showing for 44:01 example that looking at the black population of P. S. 44:03 A. Is way more predictive than just the P. S. A. 44:07 Level which is not too helpful. 44:10 And there is a lot of research in this direction trying to help people use it markets 44:17 in ecology. Then many people are trying to identify early 44:21 cancer markers, which I'm not too optimistic because you know, 44:26 we have a couple of cells in the trillions of cells and you cannot really expect these few 44:32 cells to produce something which you can measure in plasma. 44:35 So what we can measure. We can probably measure response of the immune 44:39 system two early stage cancer which will probably not not be too 44:45 specific. So I would guess majority of solid cancers 44:49 would have a similar response which we could then measure. 44:53 But we are attempting for example to predict um the 45:00 period of before the tumor will come back or we are trying we have some paper now in the 45:06 review predicting the response of different biological therapist. 45:11 Because for example, we know that uh the one special feature of antibodies called 45:18 called the constellation of the core of yukos is has a hundredfold effect on antibody 45:24 dependent sellers that existed. 45:26 So the final companies are now developing Gleicher engineered molecular antibodies where 45:32 glide can still are altered and make them more efficient. 45:35 And but this also comes in the context of isolation of patients. 45:39 You have to look at the patient to see how your drug will help. 45:43 So there is progress but it it will take it will take years before it's actually 45:50 really useful. - So the measuring the glycol isolation of P. 45:54 S. A. Is that test available for people or no? 45:58 - Now there's just few few research papers showing that if you look at the glass icons and P. 46:02 S. A. It is more predictive than just a P. S. A. 46:05 Level. I don't know any lab which is offering this as 46:09 a as a commercial testing. - Okay. Yeah so this and that's what's exciting 46:14 with the science is that I mean what you're doing, we're looking ahead into the future. 46:19 You know seeing you know what what is the possibility of of kind of the next step and by 46:25 exploring this type of science and just like the genomic pro you know project 46:32 that that you know the initiated and all the advances that we've come. 46:36 You know that we've done just based upon that - And this is actually extremely frustrating 46:41 because you know we know from science that some things could be 46:48 helpful could be much more informative but we cannot actually use it because there are so 46:55 many steps before science become diagnostics. And this is why we try to 47:01 develop these called the lifestyle test measuring the lycan age, 47:07 the metabolic age because then people can already use it. 47:12 It's not diagnostics but it's giving information which then well educated physicians 47:18 can use to also help to make a better diagnosis. So it's a kind of a middle step 47:25 between not being available at all like the P. S. A. 47:28 At the moment and being developed as a full diagnostic test which takes time. 47:35 - So are there things that we can do to kind of improve argh likens? 47:40 I mean obviously we can, you know we can kind of measure the Glicken age and then you know we 47:45 create a change and now we can see if it gets better but kind of as a whole, 47:50 you know like if the person is deficient in certain amino acid then you eat that amino acid. 47:55 I mean can you do something similar with publicans to improve your Glickman's? 47:59 - So there's a lot of research in that direction. 48:03 But since there is no standard human, there is no standardized recommendation and and like an 48:08 age as the company also offers the personalized consulting. 48:12 So if you buy a test you also get the first consultation as a part of the package where 48:19 people with experience about changing your icons can help an individual patient 48:26 and there are also some clinics A couple of them in us which we already did hundreds of 48:30 patients and they have experienced what works and what doesn't work. 48:35 For example, there's one clinic in New York in which more or less everybody becomes 15-20 48:41 years younger after half a year in the program. So there are things which work, 48:47 but they are individualized and it has to be done under the provision of a certified health 48:53 care provider. - Well, Professor Lauc it's been such a 48:58 pleasure, such an honor. And it's amazing this science that you are 49:03 driving forward. And I'm so excited to kind of to see what will 49:08 evolve, you know, the next decade or so. And with the tools, 49:13 it sounds like, you know, being able then to measure a kind of a high output uh that you 49:20 you're able then to, I mean, the science is able to move forward and in a much more rapid 49:25 pace. So thank you so much for for sharing all of 49:29 this. And then also then offering things 49:32 to the public so they can get familiar with lichens. 49:36 And then also we will be able to start to incorporate that into our lifestyle changes to 49:42 improve our life. So thank you - And thank you for the invitation 49:47 and for your interest to learn about blackens and teach other people about the importance of 49:52 blackness - Thank you
Comments